Concepedia

Gordon S. Baxter

GS

24

Publications

2K

Citations

21

H-Index

1986

Active since

Affiliations

New Frontier(Current)

Molecular Discovery (United Kingdom)

Institute of Organic Chemistry

Bradford Royal Infirmary

University of Bradford

Gordon S. Baxter is an author at New Frontier specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1986–2019

24

Publications

24

<i>In vitro</i>and<i>in vivo</i>profile of SB 206553, a potent 5‐HT<sub>2C</sub>/5‐HT<sub>2B</sub>receptor antagonist with anxiolytic‐like properties

G.A. Kennett, Martyn Wood, Fiona Bright et al. · British Journal of Pharmacology · 1996 · 240 citations · Full text

Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system

Mark Duxon, Thomas P. Flanigan, A.C. Reavley et al. · Neuroscience · 1997 · 205 citations

, , +11

5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae

Gordon S. Baxter, Douglas A. Craig, David E. Clarke · Naunyn-Schmiedeberg s Archives of Pharmacology · 1991 · 203 citations

, , +7

EP<sub>4</sub> prostanoid receptor‐mediated vasodilatation of human middle cerebral arteries

Richard J. Davis, Colin E. Murdoch, Mozam Ali et al. · British Journal of Pharmacology · 2004 · 119 citations · Full text

, , +17

5‐HT<sub>2B</sub> receptors play a key role in mediating the excitatory effects of 5‐HT in human colon <i>in vitro</i>

R. A. Borman, Nicholas S. Tilford, Dan W. Harmer et al. · British Journal of Pharmacology · 2002 · 115 citations · Full text

, , +18

Rows per page

1–5 of 24